EP1948608 - PHARMACEUTICAL SALTS AND POLYMORPHS OF N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO)IMINOMETHYL]BENZOYL]AMINO]-5-METHOXY-BENZAMIDE , A FACTOR XA INHIBITOR [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 18.01.2013 Database last updated on 12.07.2024 | Most recent event Tooltip | 18.07.2014 | Lapse of the patent in a contracting state New state(s): HU | published on 20.08.2014 [2014/34] | Applicant(s) | For all designated states MILLENNIUM PHARMACEUTICALS, INC. 40 Landsdowne Street Cambridge, MA 02139 / US | [2008/31] | Inventor(s) | 01 /
GRANT, Craig 10 Burgley Rise Burwell CB5 0LW / GB | 02 /
KANTER, James P. 9591 Alcosta Blvd. San Ramon, CA 94583 / US | 03 /
LANGLANDS, Graeme 44 Northfield Park Soham, Cambs CB7 5UZ / GB | [2008/31] | Representative(s) | Sexton, Jane Helen J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | [N/P] |
Former [2012/11] | Sexton, Jane Helen J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB | ||
Former [2008/31] | Sexton, Jane Helen J.A. Kemp & Co. 14 South Square Gray's Inn London WC1R 5JJ / GB | Application number, filing date | 06837238.2 | 07.11.2006 | [2008/31] | WO2006US43635 | Priority number, date | US20050735224P | 08.11.2005 Original published format: US 735224 P | [2008/31] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2007056517 | Date: | 18.05.2007 | Language: | EN | [2007/20] | Type: | A2 Application without search report | No.: | EP1948608 | Date: | 30.07.2008 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.05.2007 takes the place of the publication of the European patent application. | [2008/31] | Type: | B1 Patent specification | No.: | EP1948608 | Date: | 14.03.2012 | Language: | EN | [2012/11] | Search report(s) | International search report - published on: | EP | 17.04.2008 | Classification | IPC: | C07D213/75 | [2008/31] | CPC: |
A61K31/44 (EP,KR,US);
A61K31/194 (EP,US);
A61K31/616 (EP,US);
A61K9/20 (US);
A61P11/00 (EP);
A61P43/00 (EP);
A61P7/02 (EP);
A61P9/00 (EP);
A61P9/10 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/31] | Title | German: | PHARMAZEUTISCHE SALZE UND POLYMORPHE AUS N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO)IMINOMETHYL]BENZOYL]AMINO]-5-METHOXY-BENZAMID, EINEM FAKTOR-XA-HEMMER | [2008/31] | English: | PHARMACEUTICAL SALTS AND POLYMORPHS OF N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO)IMINOMETHYL]BENZOYL]AMINO]-5-METHOXY-BENZAMIDE , A FACTOR XA INHIBITOR | [2008/31] | French: | SELS PHARMACEUTIQUES ET POLYMORPHES DU N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO)IMINOMETHYL]BENZOYL]AMINO]-5-METHOXY-BENZAMIDE, UN INHIBITEUR DU FACTEUR X | [2008/31] | Entry into regional phase | 31.03.2008 | National basic fee paid | 31.03.2008 | Designation fee(s) paid | 31.03.2008 | Examination fee paid | Examination procedure | 31.03.2008 | Examination requested [2008/31] | 28.12.2010 | Despatch of a communication from the examining division (Time limit: M04) | 05.05.2011 | Reply to a communication from the examining division | 08.06.2011 | Communication of intention to grant the patent | 14.10.2011 | Fee for grant paid | 14.10.2011 | Fee for publishing/printing paid | Divisional application(s) | EP11187927.6 / EP2431358 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 28.12.2010 | Opposition(s) | 17.12.2012 | No opposition filed within time limit [2013/08] | Fees paid | Renewal fee | 17.11.2008 | Renewal fee patent year 03 | 24.11.2009 | Renewal fee patent year 04 | 23.11.2010 | Renewal fee patent year 05 | 23.11.2011 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 07.11.2006 | CY | 14.03.2012 | CZ | 14.03.2012 | EE | 14.03.2012 | LT | 14.03.2012 | LV | 14.03.2012 | PL | 14.03.2012 | RO | 14.03.2012 | SI | 14.03.2012 | SK | 14.03.2012 | BG | 14.06.2012 | IS | 14.07.2012 | LU | 07.11.2012 | [2014/34] |
Former [2014/27] | CY | 14.03.2012 | |
CZ | 14.03.2012 | ||
EE | 14.03.2012 | ||
LT | 14.03.2012 | ||
LV | 14.03.2012 | ||
PL | 14.03.2012 | ||
RO | 14.03.2012 | ||
SI | 14.03.2012 | ||
SK | 14.03.2012 | ||
BG | 14.06.2012 | ||
IS | 14.07.2012 | ||
LU | 07.11.2012 | ||
Former [2013/33] | CY | 14.03.2012 | |
CZ | 14.03.2012 | ||
EE | 14.03.2012 | ||
LT | 14.03.2012 | ||
LV | 14.03.2012 | ||
PL | 14.03.2012 | ||
RO | 14.03.2012 | ||
SI | 14.03.2012 | ||
SK | 14.03.2012 | ||
BG | 14.06.2012 | ||
IS | 14.07.2012 | ||
Former [2012/50] | CY | 14.03.2012 | |
CZ | 14.03.2012 | ||
EE | 14.03.2012 | ||
LT | 14.03.2012 | ||
LV | 14.03.2012 | ||
PL | 14.03.2012 | ||
RO | 14.03.2012 | ||
SI | 14.03.2012 | ||
SK | 14.03.2012 | ||
IS | 14.07.2012 | ||
Former [2012/49] | CY | 14.03.2012 | |
CZ | 14.03.2012 | ||
EE | 14.03.2012 | ||
LT | 14.03.2012 | ||
LV | 14.03.2012 | ||
PL | 14.03.2012 | ||
RO | 14.03.2012 | ||
SI | 14.03.2012 | ||
IS | 14.07.2012 | ||
Former [2012/48] | CY | 14.03.2012 | |
EE | 14.03.2012 | ||
LT | 14.03.2012 | ||
LV | 14.03.2012 | ||
Former [2012/41] | CY | 14.03.2012 | |
LT | 14.03.2012 | ||
LV | 14.03.2012 | ||
Former [2012/39] | LT | 14.03.2012 | |
LV | 14.03.2012 | ||
Former [2012/33] | LT | 14.03.2012 | Cited in | International search | [DX]US6376515 (ZHU BING-YAN [US], et al) [DX] 1-28 * the whole document * * example 206 ** example 261 * |